P2Y12, a New Platelet ADP Receptor, Target of Clopidogrel
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference23 articles.
1. Clopidogrel, a novel antiplatelet and antithrombotic agent;Herbert;Cardiovasc. Drug Rev.,1993
2. Pharmacology of ticlopidine and clopidogrel;Savi;Haematology,2000
3. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
4. Binding of [3H]-2-methylthio ADP to rat platelets—Effect of clopidogrel and ticlopidine;Savi;J. Pharmacol. Exp. Ther.,1994
5. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase;Mills;Arterioscler. Thromb.,1992
Cited by 204 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions;Biomedicines;2024-07-26
2. Prodrug Rewards in Medicinal Chemistry: An Advance and Challenges Approach for Drug Designing;Chemistry & Biodiversity;2023-11
3. Clopidogrel Administration Impairs Post-Stroke Learning and Memory Recovery in Mice;International Journal of Molecular Sciences;2023-07-20
4. Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease;Kardiologia Polska;2023-06-29
5. P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition;Molecular Therapy;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3